2 
Conditions of restriction 
(b) the training elements in points (a) and (b) of 
paragraph 5 for the following uses: 
— handling open mixtures at ambient tempera- 
ture (including foam tunnels); 
— spraying in a ventilated booth; 
— application by roller; 
— application by brush; 
— application by dipping and pouring; 
— mechanical post treatment (e.g. cutting) of 
not fully cured articles which are not warm 
anymore; 
— cleaning and waste; 
— any other uses with similar exposure through 
the dermal and/or inhalation route; 
(c) the training elements in points (a), (b) and (c) of 
paragraph 5 for the following uses: 
— handling incompletely cured articles (e.g. 
freshly cured, still warm); 
— foundry applications; 
— maintenance and repair that needs access to 
equipment; 
— open handling of warm or hot formulations 
(> 45 °C); 
— spraying in open air, with limited or only 
natural ventilation (includes large industry 
working halls) and spraying with high energy 
(e.g. foams, elastomers); 
— and any other uses with similar exposure 
through the dermal and/or inhalation route. 
5. Training elements: 
(a) general training, including on-line training, on: 
— chemistry of diisocyanates; 
— toxicity hazards (including acute toxicity); 
— exposure to diisocyanates; 
— occupational exposure limit values; 
— how sensitisation can develop; 
— odour as indication of hazard; 
— importance of volatility for risk; 
— viscosity, temperature, and molecular weight 
of diisocyanates; 
▼M59

 
02006R1907 — EN — 17.12.2022 — 056.001 — 283 
Column 1 
Designation of the substance, of the group of substances or of the 
mixture 
Column 2 
Conditions of restriction 
— personal hygiene; 
— personal protective equipment needed, in- 
cluding practical instructions for its correct 
use and its limitations; 
— risk of dermal contact and inhalation expo- 
sure; 
— risk in relation to application process used; 
— skin and inhalation protection scheme; 
— ventilation; 
— cleaning, leakages, maintenance; 
— discarding empty packaging; 
— protection of bystanders; 
— identification of critical handling stages; 
— specific national code systems (if applicable); 
— behaviour-based safety; 
— certification or documented proof that train- 
ing has been successfully completed 
(b) intermediate level training, including on-line 
training, on: 
— additional behaviour-based aspects; 
— maintenance; 
— management of change; 
— evaluation of existing safety instructions; 
— risk in relation to application process used; 
— certification or documented proof that train- 
ing has been successfully completed 
(c) advanced training, including on-line training, on: 
— any additional certification needed for the 
specific uses covered; 
— spraying outside a spraying booth; 
— open handling of hot or warm formulations 
(> 45 °C); 
— certification or documented proof that train- 
ing has been successfully completed 
▼M59

 
02006R1907 — EN — 17.12.2022 — 056.001 — 284 
Column 1 
Designation of the substance, of the group of substances or of the 
mixture 
Column 2 
Conditions of restriction 
6. The training shall comply with the provisions set by 
the Member State in which the industrial or 
professional user(s) operate. Member States may 
implement or continue to apply their own national 
requirements for the use of the substance(s) or 
mixture(s), as long as the minimum requirements set 
out in paragraphs 4 and 5 are met. 
7. The supplier referred to in point (b) of paragraph 2 
shall ensure that the recipient is provided with 
training material and courses pursuant to paragraphs 
4 and 5 in the official language(s) of the Member 
State(s) where the substance(s) or mixture(s) are 
supplied. The training shall take into consideration 
the specificity of the products supplied, including 
composition, packaging, and design. 
8. The employer or self-employed shall document the 
successful completion of the training referred to in 
paragraphs 4 and 5. The training shall be renewed at 
least every five years. 
9. Member States shall include in their reports pursuant 
to Article 117(1) the following information: 
(a) any established training requirements and other 
risk management measures related to the in- 
dustrial and professional uses of diisocyanates 
foreseen in national law; 
(b) the number of cases of reported and recognised 
occupational asthma and occupational respira- 
tory and dermal diseases in relation to diisocya- 
nates; 
(c) national exposure limits for diisocyanates, if 
there are any; 
(d) information about enforcement activities related 
to this restriction. 
10. This restriction shall apply without prejudice to other 
Union legislation on the protection of safety and 
health of workers at the workplace. 
▼M60 
75. Substances falling within one or more of the following 
points: 
(a) substances classified as any of the following in Part 
3 of Annex VI to Regulation (EC) No 1272/2008: 
— carcinogen category 1A, 1B or 2, or germ cell 
mutagen category 1A, 1B or 2, but excluding 
any such substances classified due to effects 
only following exposure by inhalation 
1. Shall not be placed on the market in mixtures for 
use for tattooing purposes, and mixtures containing 
any such substances shall not be used for tattooing 
purposes, after 4 January 2022 if the substance or 
substances in question is or are present in the 
following circumstances: 
(a) in the case of a substance classified in Part 3 of 
Annex VI to Regulation (EC) No 1272/2008 as 
carcinogen category 1A, 1B or 2, or germ cell 
mutagen category 1A, 1B or 2, the substance is 
present in the mixture in a concentration equal 
to or greater than 0,00005 % by weight; 
▼M59

 
02006R1907 — EN — 17.12.2022 — 056.001 — 285 
Column 1 
Designation of the substance, of the group of substances or of the 
mixture 
Column 2 
Conditions of restriction 
— reproductive toxicant category 1A, 1B or 2 but 
excluding any such substances classified due to 
effects only following exposure by inhalation 
— skin sensitiser category 1, 1A or 1B 
— skin corrosive category 1, 1A, 1B or 1C or skin 
irritant category 2 
— serious eye damage category 1 or eye irritant 
category 2 
(b) substances listed in Annex II to Regulation (EC) 
No 1223/2009 of the European Parliament and of 
the Council (*) 
(c) substances listed in Annex IV to Regulation (EC) 
No 1223/2009 for which a condition is specified in 
at least one of the columns g, h and i of the table in 
that Annex 
(d) substances listed in Appendix 13 to this Annex. 
The ancillary requirements in paragraphs 7 and 8 of 
column 2 of this entry apply to all mixtures for use 
for tattooing purposes, whether or not they contain a 
substance falling within points (a) to (d) of this column 
of this entry. 
(b) in the case of a substance classified in Part 3 of 
Annex VI to Regulation (EC) No 1272/2008 as 
reproductive toxicant category 1A, 1B or 2, the 
substance is present in the mixture in a 
concentration equal to or greater than 0,001 % 
by weight; 
(c) in the case of a substance classified in Part 3 of 
Annex VI to Regulation (EC) No 1272/2008 as 
skin sensitiser category 1, 1A or 1B, the 
substance is present in the mixture in a 
concentration equal to or greater than 0,001 % 
by weight; 
(d) in the case of a substance classified in Part 3 of 
Annex VI to Regulation (EC) No 1272/2008 as 
skin corrosive category 1, 1A, 1B or 1C or skin 
irritant category 2, or as serious eye damage 
category 1 or eye irritant category 2, the 
substance is present in the mixture in a 
concentration equal to or greater than: 
(i) 0,1 % by weight, if the substance is used 
solely as a pH regulator; 
(ii) 0,01 % by weight, in all other cases; 
(e) in the case of a substance listed in Annex II to 
Regulation (EC) No 1223/2009 (*), the sub- 
stance is present in the mixture in a concentra- 
tion equal to or greater than 0,00005 % by 
weight; 
(f) in the case of a substance for which a condition 
of one or more of the following kinds is 
specified in column g (Product type, Body 
parts) of the table in Annex IV to Regulation 
(EC) No 1223/2009, the substance is present in 
the mixture in a concentration equal to or 
greater than 0,00005 % by weight: 
(i) 
‘Rinse-off products’; 
(ii) ‘Not to be used in products applied on 
mucous membranes’; 
(iii) ‘Not to be used in eye products’; 
▼M60

 
02006R1907 — EN — 17.12.2022 — 056.001 — 286 
Column 1 
Designation of the substance, of the group of substances or of the 
mixture 
Column 2 
Conditions of restriction 
(g) in the case of a substance for which a condition 
is specified in column h (Maximum concentra- 
tion in ready for use preparation) or column i 
(Other) of the table in Annex IV to Regulation 
(EC) No 1223/2009, the substance is present in 
the mixture in a concentration, or in some other 
way, that does not accord with the condition 
specified in that column; 
(h) in the case of a substance listed in Appendix 13 
to this Annex, the substance is present in the 
mixture in a concentration equal to or greater 
than the concentration limit specified for that 
substance in that Appendix. 
2. 
For the purposes of this entry use of a mixture ‘for 
tattooing purposes’ means injection or introduction 
of the mixture into a person’s skin, mucous 
membrane or eyeball, by any process or procedure 
(including procedures commonly referred to as 
permanent make-up, cosmetic tattooing, micro- 
blading and micro-pigmentation), with the aim of 
making a mark or design on his or her body. 
3. 
If a substance not listed in Appendix 13 falls within 
more than one of points (a) to (g) of paragraph 1, the 
strictest concentration limit laid down in the points 
in question shall apply to that substance. If a 
substance listed in Appendix 13 also falls within 
one or more of points (a) to (g) of paragraph 1, the 
concentration limit laid down in point (h) of 
paragraph 1 shall apply to that substance. 
4. 
By way of derogation, paragraph 1 shall not apply 
t